← Back to searchRecruitingRecruiting
Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
NCT05845801 · Azienda Ospedaliera Universitaria Integrata Verona
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.
Eligibility criteria
Inclusion Criteria:
* Age ≤55 years old at the time of diagnosis of pancreatic cancer
* Age ≥ 18 years
* Written informed consent obtained.
Exclusion Criteria:
* Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor)
* Absence of informed consent.
* Age \< 18 years or \> 55 years old at the time of diagnosis of pancreatic cancer
Study design
Enrollment target: 3000 participants
Age groups: adult
Timeline
Starts: 2022-12-07
Estimated completion: 2052-09-30
Last updated: 2023-05-06
Interventions
Other: Register
Primary outcomes
- • Register of young PDAC patients (30 years)
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona · other
Contacts & investigators
ContactFabio Casciani · contact · fabio.casciani@univr.it · 0458124671
All locations (1)
AOUI VeronaRecruiting
Verona, Italy